Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-30

Clinical Trial Update: Safety and Performance of a Pulsed Field Device for Global Mapping and Ablation of the Left Atrium for the Treatment of Atrial Fibrillation [NA]

View source ↗

Summary

Clinical trial update for Kardium's pulsed field ablation device evaluating mapping and ablation of the left atrium in atrial fibrillation. The study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Kardium pulsed field ablation device

Snippet

Sponsor: Kardium Inc. | Conditions: Atrial Fibrillation | NA | Status: RECRUITING